跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
APO-FLUCONAZOLE 150MG CAPSULE - HSA Drug Approval Details
Approvals
/
HSA
/
APO-FLUCONAZOLE 150MG CAPSULE
Approved
THERAPEUTIC
APO-FLUCONAZOLE 150MG CAPSULE
APOTEX INC (CANADA)
🇸🇬 Health Sciences Authority
Approval Date
Aug 3, 2007
Approval ID
66177695a05b79ec
Company
APOTEX INC (CANADA)
Type
Therapeutic
Approval Details
Approval Id
66177695a05b79ec
Drug Name
APO-FLUCONAZOLE 150MG CAPSULE
Product Name
APO-FLUCONAZOLE 150MG CAPSULE
Approval Number
SIN13329P
Approval Date
2007-08-03
Registrant
PHARMAFORTE SINGAPORE PTE LTD
Licence Holder
PHARMAFORTE SINGAPORE PTE LTD
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
CAPSULE
Route Of Administration
ORAL
Atc Code
J02AC01
Atc Item Name
fluconazole
Pharma Manufacturer Name
PHARMAFORTE SINGAPORE PTE LTD
Company Detail Path
/organization/pharmaforte-singapore-pte-ltd
Active Ingredients
Fluconazole
150 mg
Fluconazole
150 mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Aug 3, 2007
Approval ID
66177695a05b79ec
Type
Therapeutic
Back to HSA Approvals